![Diclofenac Sodium 3% Gel for the Management of Actinic Keratosis: 10+ Years of Cumulative Evidence of Efficacy and Safety - JDDonline - Journal of Drugs in Dermatology Diclofenac Sodium 3% Gel for the Management of Actinic Keratosis: 10+ Years of Cumulative Evidence of Efficacy and Safety - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_1795/table1.png)
Diclofenac Sodium 3% Gel for the Management of Actinic Keratosis: 10+ Years of Cumulative Evidence of Efficacy and Safety - JDDonline - Journal of Drugs in Dermatology
![Figure 1 from Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index | Semantic Scholar Figure 1 from Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0c1520982c57318122fa0c1c3dde0899d14647b0/3-Figure1-1.png)
Figure 1 from Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index | Semantic Scholar
![JAMA Internal Medicine on X: "Topical NSAIDs are associated with greater pain relief without increase in adverse events when treating musculoskeletal conditions such as sprains, strains, and contusions. https://t.co/OWr2KcA9tv https://t.co/ZHtsZcn4x6" / X JAMA Internal Medicine on X: "Topical NSAIDs are associated with greater pain relief without increase in adverse events when treating musculoskeletal conditions such as sprains, strains, and contusions. https://t.co/OWr2KcA9tv https://t.co/ZHtsZcn4x6" / X](https://pbs.twimg.com/media/DQ5Q8jMWkAAB4w4.jpg)